AAAAAA
Results:
1-8
|
Results: 8
Authors:
Martinot-Peignoux, M
Boyer, N
Cazals-Hatem, D
Pham, BN
Gervais, A
Le Breton, V
Levy, S
Degott, C
Valla, DC
Marcellin, P
Citation: M. Martinot-peignoux et al., Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA, HEPATOLOGY, 34(5), 2001, pp. 1000-1005
Authors:
Pessione, F
Ramond, MJ
Njapoum, C
Duchatelle, V
Degott, C
Erlinger, S
Rueff, B
Valla, DC
Degos, F
Citation: F. Pessione et al., Cigarette smoking and hepatic lesions in patients with chronic hepatitis C, HEPATOLOGY, 34(1), 2001, pp. 121-125
Authors:
Valla, DC
Degos, F
Citation: Dc. Valla et F. Degos, Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus, J HEPATOL, 34(4), 2001, pp. 606-609
Authors:
Deltenre, P
Denninger, MH
Hillaire, S
Guillin, MC
Casadevall, N
Briere, J
Erlinger, S
Valla, DC
Citation: P. Deltenre et al., Factor V Leiden related Budd-Chiari syndrome, GUT, 48(2), 2001, pp. 264-268
Authors:
Valla, DC
Condat, B
Citation: Dc. Valla et B. Condat, Portal vein thrombosis in adults: pathophysiology, pathogenesis and management, J HEPATOL, 32(5), 2000, pp. 865-871
Authors:
Valla, DC
Citation: Dc. Valla, Portal vein thrombosis and prothrombotic disorders, J GASTR HEP, 14(11), 1999, pp. 1051-1052
Authors:
Ramond, MJ
Lebrec, D
Valla, DC
Citation: Mj. Ramond et al., Endoscopic band ligation versus beta-blockers for the prevention of first bleeding of esophageal varices: are randomized studies necessary?, GASTRO CL B, 23(8-9), 1999, pp. 874-877
Authors:
Valla, DC
Chevallier, M
Marcellin, P
Payen, JL
Trepo, C
Fonck, M
Bourliere, M
Boucher, E
Miguet, JP
Parlier, D
Lemonnier, C
Opolon, P
Citation: Dc. Valla et al., Treatment of hepatitis c virus-related cirrhosis: A randomized, controlledtrial of interferon alfa-2b versus no treatment, HEPATOLOGY, 29(6), 1999, pp. 1870-1875
Risultati:
1-8
|